Business Segments Legend Biotech Corporation
Equities
LEGN
US52490G1022
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.46 USD | +5.24% |
|
+9.87% | +21.25% |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||
Biotechnology | 78.75M | 91.56M | 117M | 285M | 627M | |||
Total Assets | 721M | 1.12B | 1.33B | 1.85B | 1.67B | |||
Interest Expense | -195K | -900K | -10.8M | -21.79M | -21.62M | |||
Income Tax Expense | -4.14M | 1K | 625K | -1.86M | 18.89M | |||
CAPEX | -49.78M | -47.11M | -22.28M | -20.08M | -14.1M | |||
EBT | -308M | -386M | -446M | -520M | -158M | |||
D&A | 9.74M | 12.54M | 15.92M | 18.53M | 21.59M | |||
Net Income | -303M | -386M | -446M | -518M | -177M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
United States of America | - | 86.37M | 117M | 270M | 579M | |||
Total Assets | - | 104M | 114M | 151M | 188M | |||
Europe | - | - | - | 15.07M | 47.87M | |||
Total Assets | - | - | - | 139M | 147M | |||
China | - | 3.42M | 328K | 179K | 320K | |||
Total Assets | 43.95M | 50.8M | 54.51M | 56.01M | 46.08M | |||
North America | 75.68M | - | - | - | - | |||
Other | - | - | 75K | - | - | |||
Total Assets | 84.2M | 10.46M | 62.91M | - | - |
- Stock Market
- Equities
- LEGN Stock
- Financials Legend Biotech Corporation
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition